Psychedelic Drugs Market, by Drug Type, By Application, By Distribution Channel, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030

List of Tables

REPORT HIGHLIGHT

Psychedelic Drugs Market size was valued at USD 4,870.12 Million in 2022, expanding at a CAGR of 13.46% from 2023 to 2030.

Substances categorized as "psychedelics" possess the capacity to induce profound alterations in perception, cognitive processes, and emotional states, often leading to intense sensory encounters and potentially life-altering insights. This category includes substances like psilocybin mushrooms, DMT (dimethyltryptamine), and LSD (lysergic acid diethylamide). These compounds exert their effects by targeting specific receptors in the brain, resulting in hallucinogenic phenomena, heightened emotional responses, and shifts in consciousness.

While these chemical agents have garnered scientific attention for their potential therapeutic and spiritual applications, their usage carries inherent risks. These hazards encompass adverse side effects and psychological challenges that individuals may encounter when engaging with these substances.

Psychedelic Drugs Market - Market Dynamics:

Increasing awareness about the importance of addressing mental health concerns

The growth of the market is significantly shaped by the demand for solutions addressing the challenges of urban congestion and transportation inefficiencies. Emerging technologies and innovative mobility solutions are playing a pivotal role in redefining urban transportation landscapes, offering novel approaches to alleviate traffic congestion and reduce environmental impact. Throughout the forecasted period, it is anticipated that government initiatives, public-private collaborations, and advocacy campaigns promoting sustainable urban mobility will drive market expansion.

For example, in recent decades, organizations like the Urban Mobility Foundation have spearheaded initiatives aimed at transforming urban transportation paradigms. Their efforts have resulted in the development and adoption of sustainable mobility practices, contributing to more efficient and eco-friendly urban commuting options.

Psychedelic Drugs Market - Key Insights:

As per the insights provided by our research analysts, the global Market for Psychedelic Drugs is poised to experience a robust annual growth rate, with a projected Compound Annual Growth Rate (CAGR) of approximately 14.2% throughout the forecast period spanning from 2023 to 2030.

This industry's growth trajectory is underpinned by significant factors, primarily the increasing recognition of the critical need to address mental health challenges on a global scale.

Within the realm of drug categorization, the segment dedicated to psilocybin emerged as the dominant player in terms of market share for the year 2022.

Furthermore, when considering application segmentation, the category related to the treatment of resistant depression stood out as the frontrunner in 2022.

Examining distribution channels, hospitals took the lead in 2022 in terms of market presence.

In geographical terms, North America emerged as the primary revenue contributor in the year 2022.

Psychedelic Drugs Market- Segmentation Analysis:

The Global Market for Psychedelic Drugs exhibits a comprehensive segmentation structure, incorporating Drug Type, Application, Technology, and Geographical Region as its key categorizations.

Within the spectrum of Drug Type classification, the market presents a diverse array of categories, including Ketamine, Gamma Hydroxybutyric Acid (GHB), Lysergic Acid Diethylamide (LSD), Psilocybin, 3,4-MethylEnedioxyMethamphetamine, and various other drug types. Notably, the market's landscape is currently dominated by Psilocybin. This particular compound has been at the forefront of clinical investigations, with studies focusing on its potential efficacy in treating a spectrum of conditions such as addiction, anxiety, depression, and end-of-life distress. The preliminary research findings have unveiled promising outcomes, prompting considerable interest and financial support for the development of treatment modalities based on Psilocybin.

Psychedelic Drugs Market- Competitive Landscape:

Enterprises employ diverse strategies to bring their products to market, utilizing an array of distribution channels such as corporate websites, online retail platforms, brick-and-mortar retailers, distribution partners, and direct-to-consumer models. Product manufacturers engage in competition across multiple fronts, including pricing strategies, product performance, manufacturing techniques, technological innovation, brand reputation, and product availability.

To fortify their market presence and expand their market share, companies employ a range of tactics. These include product portfolio enhancements through new product launches, the expansion of distribution networks, increased investments in research and development, and participation in mergers and acquisitions.

For instance, in October 2022, Numinus Wellness Inc., a mental health care organization dedicated to advancing evidence-based, safe psychedelic-assisted treatments, introduced its Ketamine for Serious and Chronic Medical Illness Program. This innovative initiative is expected to roll out initially in Numinus clinics located in British Columbia, Utah, and Quebec, signifying a progressive approach to addressing medical conditions through novel therapeutic avenues.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PSYCHEDELIC DRUGS MARKET KEY PLAYERS

Silo Wellness
Revive Therapeutics
PsyBio Therapeutics
Numinus Wellness
Mydecine Innovations Group
MindMed
MagicMed Industries
Field Trip Health
Entheon Biomedical
Eleusis Ltd.
Cybin Inc.
Compass Pathways
Bright Minds Biosciences
Beckley Psytech
Atai Life Sciences

GLOBAL PSYCHEDELIC DRUGS MARKET, BY DRUG TYPE

Ketamine
Gamma Hydroxybutyric Acid (GHB)
Lysergic Acid Diethylamide (LSD)
Psilocybin
3,4-MethylEnedioxyMethamphetamine
Other Drug Types

GLOBAL PSYCHEDELIC DRUGS MARKET, BY APPLICATION

Opiate Addiction
Treatment-Resistant Depression
Narcolepsy
Post-traumatic Stress Disorder
Panic Disorder
Others Applications

GLOBAL PSYCHEDELIC DRUGS MARKET, BY DISTRIBUTION

Retail Pharmacy
Hospital Pharmacy
Online Distribution Channel

GLOBAL PSYCHEDELIC DRUGS MARKET, BY REGION

North America
- The U.S.
- Canada

Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Russia
- Netherlands
- Sweden
- Poland
- Rest of Europe

Asia Pacific
- India
- China
- South Korea
- Japan
- Australia
- Thailand
- Indonesia
- Philippines
- Rest of APAC

Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM

The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA

Product Code: ANV1666

1. Psychedelic Drugs Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Psychedelic Drugs Market Snippet by Drug Type
- 2.1.2. Psychedelic Drugs Market Snippet by Application
- 2.1.3. Psychedelic Drugs Market Snippet by Distribution
- 2.1.4. Psychedelic Drugs Market Snippet by Country
- 2.1.5. Psychedelic Drugs Market Snippet by Region
2.2. Competitive Insights

3. Psychedelic Drugs Key Market Trends

3.1. Psychedelic Drugs Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Psychedelic Drugs Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Psychedelic Drugs Market Opportunities
3.4. Psychedelic Drugs Market Future Trends

4. Psychedelic Drugs Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Psychedelic Drugs Market: COVID-19 Impact Analysis

5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments

6. Psychedelic Drugs Market Landscape

6.1. Psychedelic Drugs Market Share Analysis, 2022
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Psychedelic Drugs Market - By Drug Type

7.1. Overview
- 7.1.1. Segment Share Analysis, By Drug Type, 2022 & 2030 (%)
- 7.1.2. Ketamine
- 7.1.3. Gamma Hydroxybutyric Acid (GHB)
- 7.1.4. Lysergic Acid Diethylamide (LSD)
- 7.1.5. Psilocybin
- 7.1.6. 3,4-MethylEnedioxyMethamphetamine
- 7.1.7. Other Drug Types

8. Psychedelic Drugs Market - By Application

8.1. Overview
- 8.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
- 8.1.2. Opiate Addiction
- 8.1.3. Treatment-Resistant Depression
- 8.1.4. Narcolepsy
- 8.1.5. Post-traumatic Stress Disorder
- 8.1.6. Panic Disorder
- 8.1.7. Others Applications

9. Psychedelic Drugs Market - By Distribution

9.1. Overview
- 9.1.1. Segment Share Analysis, By Distribution, 2022 & 2030 (%)
- 9.1.2. Retail Pharmacy
- 9.1.3. Hospital Pharmacy
- 9.1.4. Online Distribution Channel

10. Psychedelic Drugs Market- By Geography

10.1. Introduction
- 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
10.2. North America
- 10.2.1. Overview
- 10.2.2. Psychedelic Drugs Key Manufacturers in North America
- 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.2.4. North America Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
- 10.2.5. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.2.6. North America Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
- 10.2.7. U.S.
  - 10.2.7.1. Overview
  - 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.2.7.3. U.S. Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
  - 10.2.7.4. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.2.7.5. U.S. Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
- 10.2.8. Canada
  - 10.2.8.1. Overview
  - 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.2.8.3. Canada Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
  - 10.2.8.4. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.2.8.5. Canada Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
10.3. Europe
- 10.3.1. Overview
- 10.3.2. Psychedelic Drugs Key Manufacturers in Europe
- 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.3.4. Europe Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
- 10.3.5. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.3.6. Europe Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
- 10.3.7. Germany
  - 10.3.7.1. Overview
  - 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.3.7.3. Germany Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
  - 10.3.7.4. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.3.7.5. Germany Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
- 10.3.8. Italy
  - 10.3.8.1. Overview
  - 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.3.8.3. Italy Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
  - 10.3.8.4. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.3.8.5. Italy Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
- 10.3.9. United Kingdom
  - 10.3.9.1. Overview
  - 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.3.9.3. United Kingdom Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
  - 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.3.9.5. United Kingdom Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
- 10.3.10. France
  - 10.3.10.1. Overview
  - 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.3.10.3. France Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
  - 10.3.10.4. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.3.10.5. France Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
- 10.3.11. Russia
  - 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.3.11.2. Russia Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
  - 10.3.11.3. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.3.11.4. Russia Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
- 10.3.12. Netherlands
  - 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.3.12.2. Netherlands Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
  - 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.3.12.4. Netherlands Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
- 10.3.13. Sweden
  - 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.3.13.2. Sweden Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
  - 10.3.13.3. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.3.13.4. Sweden Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
- 10.3.14. Poland
  - 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.3.14.2. Poland Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
  - 10.3.14.3. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.3.14.4. Poland Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
- 10.3.15. Rest of Europe
  - 10.3.15.1. Overview
  - 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.3.15.3. Rest of the Europe Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
  - 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.3.15.5. Rest of the Europe Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
10.4. Asia Pacific (APAC)
- 10.4.1. Overview
- 10.4.2. Psychedelic Drugs Key Manufacturers in Asia Pacific
- 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.4.4. Asia Pacific Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
- 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.4.6. Asia Pacific Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
- 10.4.7. India
  - 10.4.7.1. Overview
  - 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.4.7.3. India Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
  - 10.4.7.4. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.4.7.5. India Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
- 10.4.8. China
  - 10.4.8.1. Overview
  - 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.4.8.3. China Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
  - 10.4.8.4. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.4.8.5. China Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
- 10.4.9. Japan
  - 10.4.9.1. Overview
  - 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.4.9.3. Japan Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
  - 10.4.9.4. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.4.9.5. Japan Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
- 10.4.10. South Korea
  - 10.4.10.1. Overview
  - 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.4.10.3. South Korea Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
  - 10.4.10.4. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.4.10.5. South Korea Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
- 10.4.11. Australia
  - 10.4.11.1. Overview
  - 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.4.11.3. Australia Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
  - 10.4.11.4. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.4.11.5. Australia Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
- 10.4.12. Thailand
  - 10.4.12.1. Overview
  - 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.4.12.3. Thailand Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
  - 10.4.12.4. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.4.12.5. Thailand Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
- 10.4.13. Indonesia
  - 10.4.13.1. Overview
  - 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.4.13.3. Indonesia Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
  - 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.4.13.5. Indonesia Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
- 10.4.14. Philippines
  - 10.4.14.1. Overview
  - 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.4.14.3. Philippines Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
  - 10.4.14.4. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.4.14.5. Philippines Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
- 10.4.15. Rest of APAC
  - 10.4.15.1. Overview
  - 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.4.15.3. Rest of APAC Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
  - 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.4.15.5. Rest of APAC Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
10.5. Latin America
- 10.5.1. Overview
- 10.5.2. Psychedelic Drugs Key Manufacturers in Latin America
- 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.5.4. Latin America Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
- 10.5.5. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.5.6. Latin America Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
- 10.5.7. Brazil
  - 10.5.7.1. Overview
  - 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.5.7.3. Brazil Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
  - 10.5.7.4. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.5.7.5. Brazil Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
- 10.5.8. Mexico
  - 10.5.8.1. Overview
  - 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.5.8.3. Mexico Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
  - 10.5.8.4. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.5.8.5. Mexico Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
- 10.5.9. Argentina
  - 10.5.9.1. Overview
  - 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.5.9.3. Argentina Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
  - 10.5.9.4. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.5.9.5. Argentina Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
- 10.5.10. Colombia
  - 10.5.10.1. Overview
  - 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.5.10.3. Colombia Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
  - 10.5.10.4. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.5.10.5. Colombia Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
- 10.5.11. Rest of LATAM
  - 10.5.11.1. Overview
  - 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.5.11.3. Rest of LATAM Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
  - 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.5.11.5. Rest of LATAM Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
10.6. Middle East and Africa
- 10.6.1. Overview
- 10.6.2. Psychedelic Drugs Key Manufacturers in Middle East and Africa
- 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.6.4. Middle East and Africa Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
- 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.6.6. Middle East and Africa Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
- 10.6.7. Saudi Arabia
  - 10.6.7.1. Overview
  - 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.6.7.3. Saudi Arabia Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
  - 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.6.7.5. Saudi Arabia Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
- 10.6.8. United Arab Emirates
  - 10.6.8.1. Overview
  - 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.6.8.3. United Arab Emirates Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
  - 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.6.8.5. United Arab Emirates Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
- 10.6.9. Israel
  - 10.6.9.1. Overview
  - 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.6.9.3. Israel Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
  - 10.6.9.4. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.6.9.5. Israel Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
- 10.6.10. Turkey
  - 10.6.10.1. Overview
  - 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.6.10.3. Turkey Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
  - 10.6.10.4. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.6.10.5. Turkey Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
- 10.6.11. Algeria
  - 10.6.11.1. Overview
  - 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.6.11.3. Algeria Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
  - 10.6.11.4. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.6.11.5. Algeria Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
- 10.6.12. Egypt
  - 10.6.12.1. Overview
  - 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.6.12.3. Egypt Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
  - 10.6.12.4. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.6.12.5. Egypt Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
- 10.6.13. Rest of MEA
  - 10.6.13.1. Overview
  - 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.6.13.3. Rest of MEA Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
  - 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.6.13.5. Rest of MEA Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Psychedelic Drugs Industry

11.1. Competitive Dashboard
11.2. Company Profiles
- 11.2.1. Silo Wellness
- 11.2.2. Revive Therapeutics
- 11.2.3. PsyBio Therapeutics
- 11.2.4. Numinus Wellness
- 11.2.5. Mydecine Innovations Group
- 11.2.6. MindMed
- 11.2.7. MagicMed Industries
- 11.2.8. Field Trip Health
- 11.2.9. Entheon Biomedical
- 11.2.10. Eleusis Ltd.
- 11.2.11. Cybin Inc.
- 11.2.12. Compass Pathways
- 11.2.13. Bright Minds Biosciences
- 11.2.14. Beckley Psytech
- 11.2.15. Atai Life Sciences

12. 360 Degree Analyst View

13. Appendix

13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us

Product Code: ANV1666

List of Tables

TABLE List of data sources
TABLE Market drivers; Impact Analysis
TABLE Market restraints; Impact Analysis
TABLE Psychedelic Drugs Market: Drug Type Snapshot (2022)
TABLE Segment Dashboard; Definition and Scope, by Drug Type
TABLE Global Psychedelic Drugs Market, by Drug Type 2018-2030 (USD Million)
TABLE Psychedelic Drugs Market: Application Snapshot (2022)
TABLE Segment Dashboard; Definition and Scope, by Application
TABLE Global Psychedelic Drugs Market, by Application 2018-2030 (USD Million)
TABLE Psychedelic Drugs Market: Distribution Snapshot (2022)
TABLE Segment Dashboard; Definition and Scope, by Distribution
TABLE Global Psychedelic Drugs Market, by Distribution 2018-2030 (USD Million)
TABLE Psychedelic Drugs Market: Regional snapshot (2022)
TABLE Segment Dashboard; Definition and Scope, by Region
TABLE Global Psychedelic Drugs Market, by Region 2018-2030 (USD Million)
TABLE North America Psychedelic Drugs Market, by Country, 2018-2030 (USD Million)
TABLE North America Psychedelic Drugs Market, by Drug Type, 2018-2030 (USD Million)
TABLE North America Psychedelic Drugs Market, by Application, 2018-2030 (USD Million)
TABLE North America Psychedelic Drugs Market, by Distribution, 2018-2030 (USD Million)
TABLE Europe Psychedelic Drugs Market, by Country, 2018-2030 (USD Million)
TABLE Europe Psychedelic Drugs Market, by Drug Type, 2018-2030 (USD Million)
TABLE Europe Psychedelic Drugs Market, by Application, 2018-2030 (USD Million)
TABLE Europe Psychedelic Drugs Market, by Distribution, 2018-2030 (USD Million)
TABLE Asia Pacific Psychedelic Drugs Market, by Country, 2018-2030 (USD Million)
TABLE Asia Pacific Psychedelic Drugs Market, by Drug Type, 2018-2030 (USD Million)
TABLE Asia Pacific Psychedelic Drugs Market, by Application, 2018-2030 (USD Million)
TABLE Asia Pacific Psychedelic Drugs Market, by Distribution, 2018-2030 (USD Million)
TABLE Latin America Psychedelic Drugs Market, by Country, 2018-2030 (USD Million)
TABLE Latin America Psychedelic Drugs Market, by Drug Type, 2018-2030 (USD Million)
TABLE Latin America Psychedelic Drugs Market, by Application, 2018-2030 (USD Million)
TABLE Latin America Psychedelic Drugs Market, by Distribution, 2018-2030 (USD Million)
TABLE Middle East and Africa Psychedelic Drugs Market, by Country, 2018-2030 (USD Million)
TABLE Middle East and Africa Psychedelic Drugs Market, by Drug Type, 2018-2030 (USD Million)
TABLE Middle East and Africa Psychedelic Drugs Market, by Application, 2018-2030 (USD Million)
TABLE Middle East and Africa Psychedelic Drugs Market, by Distribution, 2018-2030 (USD Million)

Psychedelic Drugs Market, by Drug Type, By Application, By Distribution Channel, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030

Description

Table of Contents

List of Tables

REPORT HIGHLIGHT

Psychedelic Drugs Market - Market Dynamics:

Psychedelic Drugs Market - Key Insights:

Psychedelic Drugs Market- Segmentation Analysis:

Psychedelic Drugs Market- Competitive Landscape:

SCOPE OF THE REPORT

GLOBAL PSYCHEDELIC DRUGS MARKET KEY PLAYERS

GLOBAL PSYCHEDELIC DRUGS MARKET, BY DRUG TYPE

GLOBAL PSYCHEDELIC DRUGS MARKET, BY APPLICATION

GLOBAL PSYCHEDELIC DRUGS MARKET, BY DISTRIBUTION

GLOBAL PSYCHEDELIC DRUGS MARKET, BY REGION

Table of Contents

1. Psychedelic Drugs Market Overview

2. Executive Summary

3. Psychedelic Drugs Key Market Trends

4. Psychedelic Drugs Industry Study

5. Psychedelic Drugs Market: COVID-19 Impact Analysis

6. Psychedelic Drugs Market Landscape

7. Psychedelic Drugs Market - By Drug Type

8. Psychedelic Drugs Market - By Application

9. Psychedelic Drugs Market - By Distribution

10. Psychedelic Drugs Market- By Geography

11. Key Vendor Analysis- Psychedelic Drugs Industry

12. 360 Degree Analyst View

13. Appendix

List of Tables